Safety during breastfeeding: Drugs, foods, environmental chemicals, and maternal infections

Cheston Berlin, John N. van den Anker

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

The two ultimate goals of using maternal medications during breastfeeding are (i) to provide definitive therapy for maternal conditions for which the drugs have been prescribed, and (ii) to assure protection of the nursing infant from any adverse event related to his/her mother's treatment. Fortunately there are only a few drugs that have been identified as potentially causing harm to the infant. Analytic techniques exist to measure compounds in concentrations as small as nanograms per liter of milk. For nearly all compounds these very small amounts would not be able to exert pharmacological activity, even if absorbed by the infant via the oral route. For environmental chemicals, this ability to measure very small amounts exceeds our knowledge of any biological activity. Concern over any possible adverse event to the nursing infant should take into account the drug, its dose, the age of the infant, recognition of the interindividual variation in drug response and the role of pharmacogenetics. The latter two variables are closely linked.

Original languageEnglish (US)
Pages (from-to)13-18
Number of pages6
JournalSeminars in Fetal and Neonatal Medicine
Volume18
Issue number1
DOIs
StatePublished - Feb 1 2013

Fingerprint

Breast Feeding
Mothers
Safety
Food
Infection
Pharmaceutical Preparations
Nursing
Aptitude
Pharmacogenetics
Milk
Pharmacology
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{1dd7bbef28184e9f8dbb6f1813af8cc2,
title = "Safety during breastfeeding: Drugs, foods, environmental chemicals, and maternal infections",
abstract = "The two ultimate goals of using maternal medications during breastfeeding are (i) to provide definitive therapy for maternal conditions for which the drugs have been prescribed, and (ii) to assure protection of the nursing infant from any adverse event related to his/her mother's treatment. Fortunately there are only a few drugs that have been identified as potentially causing harm to the infant. Analytic techniques exist to measure compounds in concentrations as small as nanograms per liter of milk. For nearly all compounds these very small amounts would not be able to exert pharmacological activity, even if absorbed by the infant via the oral route. For environmental chemicals, this ability to measure very small amounts exceeds our knowledge of any biological activity. Concern over any possible adverse event to the nursing infant should take into account the drug, its dose, the age of the infant, recognition of the interindividual variation in drug response and the role of pharmacogenetics. The latter two variables are closely linked.",
author = "Cheston Berlin and {van den Anker}, {John N.}",
year = "2013",
month = "2",
day = "1",
doi = "10.1016/j.siny.2012.09.003",
language = "English (US)",
volume = "18",
pages = "13--18",
journal = "Seminars in Fetal and Neonatal Medicine",
issn = "1744-165X",
publisher = "W.B. Saunders Ltd",
number = "1",

}

Safety during breastfeeding : Drugs, foods, environmental chemicals, and maternal infections. / Berlin, Cheston; van den Anker, John N.

In: Seminars in Fetal and Neonatal Medicine, Vol. 18, No. 1, 01.02.2013, p. 13-18.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Safety during breastfeeding

T2 - Drugs, foods, environmental chemicals, and maternal infections

AU - Berlin, Cheston

AU - van den Anker, John N.

PY - 2013/2/1

Y1 - 2013/2/1

N2 - The two ultimate goals of using maternal medications during breastfeeding are (i) to provide definitive therapy for maternal conditions for which the drugs have been prescribed, and (ii) to assure protection of the nursing infant from any adverse event related to his/her mother's treatment. Fortunately there are only a few drugs that have been identified as potentially causing harm to the infant. Analytic techniques exist to measure compounds in concentrations as small as nanograms per liter of milk. For nearly all compounds these very small amounts would not be able to exert pharmacological activity, even if absorbed by the infant via the oral route. For environmental chemicals, this ability to measure very small amounts exceeds our knowledge of any biological activity. Concern over any possible adverse event to the nursing infant should take into account the drug, its dose, the age of the infant, recognition of the interindividual variation in drug response and the role of pharmacogenetics. The latter two variables are closely linked.

AB - The two ultimate goals of using maternal medications during breastfeeding are (i) to provide definitive therapy for maternal conditions for which the drugs have been prescribed, and (ii) to assure protection of the nursing infant from any adverse event related to his/her mother's treatment. Fortunately there are only a few drugs that have been identified as potentially causing harm to the infant. Analytic techniques exist to measure compounds in concentrations as small as nanograms per liter of milk. For nearly all compounds these very small amounts would not be able to exert pharmacological activity, even if absorbed by the infant via the oral route. For environmental chemicals, this ability to measure very small amounts exceeds our knowledge of any biological activity. Concern over any possible adverse event to the nursing infant should take into account the drug, its dose, the age of the infant, recognition of the interindividual variation in drug response and the role of pharmacogenetics. The latter two variables are closely linked.

UR - http://www.scopus.com/inward/record.url?scp=84871938726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871938726&partnerID=8YFLogxK

U2 - 10.1016/j.siny.2012.09.003

DO - 10.1016/j.siny.2012.09.003

M3 - Review article

C2 - 23131768

AN - SCOPUS:84871938726

VL - 18

SP - 13

EP - 18

JO - Seminars in Fetal and Neonatal Medicine

JF - Seminars in Fetal and Neonatal Medicine

SN - 1744-165X

IS - 1

ER -